Members of our community who have lung cancer will save close to $90,000 each year after the Government listed Tagrisso on the PBS, the Federal Member for Page Kevin Hogan said.
“Patients currently pay close to $8,000 per script or almost $88,000 per year for this treatment without subsidised access through the PBS.
“Thanks to our investment, the price drops from next month to just $40.30 per script, or $6.50 for concessional patients.
Mr Hogan said subsidising medicines like Tagrisso means patients can manage their cancer at home rather than visiting the hospital for chemotherapy.
“This is the latest of nearly 2000 PBS listings worth around $10.5 billion we’ve been able to make since we came to government,” he said.
“This PBS listing was recommended by the independent Pharmaceutical Benefits Advisory Committee (PBAC).”
“Our Government continues to list every drug on the PBS approved by the PBAC to ensure that new, essential medicines are affordable for all Australians.”
“We are now making on average one new or amended PBS listing every single day.